Small‐molecule inhibitors of ubiquitin‐specific protease 7 enhance type‐I interferon antiviral efficacy by destabilizing SOCS1-Reference-Cited by-同舟云学术

Small‐molecule inhibitors of ubiquitin‐specific protease 7 enhance type‐I interferon antiviral efficacy by destabilizing SOCS1

Published:2019-12-05 Issue:3 Volume:159 Page:309-321
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Yuan Yukang¹,Miao Ying¹,Zeng Chenhua¹,Liu Jin¹²,Chen Xiangjie¹,Qian Liping¹,Wang Xiaofang¹,Qian Feng²,Yu Zhengyuan³,Wang Jun⁴,Qian Guanghui⁵,Fu Qian⁶,Lv Haitao⁵,Zheng Hui¹^ORCID

Affiliation:

1. Institutes of Biology and Medical Sciences Jiangsu Key Laboratory of Infection and Immunity Soochow University Suzhou China

2. The Affiliated Infectious Diseases Hospital of Soochow University Suzhou China

3. Department of Oncology the First Affiliated Hospital of Soochow University Suzhou China

4. Department of Intensive Care Medicine the First Affiliated Hospital of Soochow University Suzhou China

5. Institute of Pediatric Research Children's Hospital of Soochow University Suzhou China

6. Soochow University Library Suzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13147

Reference18 articles.

1. Inhibition of proteasome deubiquitinating activity as a new cancer therapy

2. Emerging Potential of Therapeutic Targeting of Ubiquitin-Specific Proteases in the Treatment of Cancer

3. Ubiquitin-based anticancer therapy: Carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors

4. Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?

5. Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP19 exerts a tumor‐promoting role in diffuse large B cell lymphoma through stabilizing PARK7;The FEBS Journal;2024-09-06

2. Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches;International Journal of Molecular Sciences;2024-08-29

3. DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1;mBio;2024-03-13

4. Ubiquitination network in the type I IFN‐induced antiviral signaling pathway;European Journal of Immunology;2023-05-28

5. RNF123 Mediates Ubiquitination and Degradation of SOCS1 To Regulate Type I Interferon Production during Duck Tembusu Virus Infection;Journal of Virology;2023-04-27